Theranos Says Only 1% of Results Affected; Some Doubt Tests
- Testing startup stands by tests, doesn’t plan more corrections
- All patients affected have been notified, company says
A logo sign outside of the headquarters of Theranos in Palo Alto, California on January 24, 2016.
Photographer: Kris Tripplaar/Sipa USA via AP PhotoThis article is for subscribers only.
Less than 1 percent of the blood test results Theranos Inc. has provided have either been voided or corrected, according to the company, which last month said it was canceling or altering tens of thousands of results, including two years of results on some of the company’s proprietary machines.
The revisions were made out of what spokeswoman Brooke Buchanan said was an abundance of caution. In response to questions from Bloomberg, the Silicon Valley startup said it has informed all patients who were affected.